Tech Company Financing Transactions
Leukogene Therapeutics Funding Round
Leukogene Therapeutics closed a venture capital round on 11/12/2025. Investors included SC Launch.
Transaction Overview
Company Name
Announced On
11/12/2025
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
SC Launch (Matt Bell)
Proceeds Purpose
This investment will allow us to advance our programs toward the clinic, strengthen Leukogene's position as a leader in developing next-generation cancer therapeutics and continue building a world-class biotech company.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
280 Calhoun St., Blue Sky Labs QE308C-D
Charleston, SC 29425
USA
Charleston, SC 29425
USA
Phone
Website
Email Address
Overview
Leukogene Therapeutics is a Charleston, SC based oncology focused biotech company, a spin-out from the Medical University of South Carolina (MUSC). Our mission is to deliver innovative immunotherapies for hard-to-treat cancers with emphasis on immunologically "cold" tumors.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sandeep Gupta
Browse more venture capital transactions:
Prev: 11/11/2025: Wonderful venture capital transaction
Next: 11/12/2025: Theo Ai venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs